All News

RheumNow Podcast square

RheumNow Podcast – Pounds of Prevention (3.5.2021)

d Jack Cush, MD

Dr. Jack Cush reviews and discusses nearly a dozen news reports and journal articles from the past week on RheumNow.com.

Read Article
Covid lung pneumonia corona (keep)

Baricitinib Therapy in Covid-19 Pneumonia

d Jack Cush, MD

The NEJM has published the results of the ACCT-2 Study,  a double-blind, randomized, placebo-controlled trial evaluating baricitinib, an inhibitor of Janus kinase 1 (JAK1) and JAK2, plus remdesivir in hospitalized adults with Covid-19. The primary outcome was the time to recovery.

Read Article
Download available--Difficult RA Defined https://t.co/6WGMEiwiUk

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow podcast now available! Listen on SoundCloud and Apple/Android podcasts. https://t.co/P6kaqZP0PJ https://t.co/BPQ5Ey7d0r

Links:

Dr. John Cush RheumNow ( View Tweet)
"... think what others won’t think; go where others won’t go; do what others won’t do; and be what others want to be." - Phil knight

Dr. John Cush RheumNow ( View Tweet)

News Feature: Baricitinib Therapy in Covid-19 Pneumonia https://t.co/b3tsLcoXay https://t.co/tjqkk1RLFZ

Links:

Dr. John Cush RheumNow ( View Tweet)
Download available--Arthritis Myths https://t.co/2Kxpou4Fbz

Links:

Dr. John Cush RheumNow ( View Tweet)

We have a robust agenda planned for RheumNow Live. Have you registered yet? https://t.co/3zMtzt4t2H https://t.co/iLNj8XEu4X

Links:

Dr. John Cush RheumNow ( View Tweet)
QD Clinic - Remission Time What to do when not quite in remission https://t.co/BjALXBPVYm https://t.co/HftUANlU1b

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow LIVE VOTE Survey (RHEUMS only): What Kind of Rheumatologist are You? General Rheum? Selective Rheum? Specialized Rheum? please vote in our quick 4Q survey https://t.co/2c5fIgcJ5X https://t.co/LgK8yiXEWC

Links:

Dr. John Cush RheumNow ( View Tweet)
Influenza Numbers are way down this year due to COVID mitigation methods, school/office closings, reduced travel/mobility. As of Jan 31st only 155 hospitalized with the flu (98% less than 2019-2020 flu season - 8,633 people were hospitalized with the flu) https://t.co/6c2YQKbt57?

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: Weight Loss to Avert Risk of Gout https://t.co/wzf69PvSJc https://t.co/Dph4OAC2Ar

Links:

Dr. John Cush RheumNow ( View Tweet)
2021 Rheumatollgy drugs lead television advertising spending: #1 Humira ($65.8 million); #6 Xeljanz ($33.9 mill); #7 Skyrizi ($40 mill); #8 Enbrel ($25.8mill); #9 Rinvo ($12+ mill) https://t.co/Pan9Vr5kLt

Links:

Dr. John Cush RheumNow ( View Tweet)

Today the FDA approved tocilizumab (Actemra) for use in Systemic Sclerosis-Associated Interstitial Lung Disease for "Slowing the rate of decline in pulmonary function in adult patients with SSc-ILD" Rec dose is 162 mg SC q week (IV dose not approved) https://t.co/HXTRPiYEfZ

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Clinic - I'm Ready to Fly It's ok to Fly, go to a Resturant and come to https://t.co/9U4LaPKfJs https://t.co/R0eYO2GiPd https://t.co/Ot9RFlmsVT

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Live is a powerful, interactive meeting delivered by researchers, educators, & clinicians. Sign up to attend virtually today. https://t.co/9IGCDMnlrb

Links:

Dr. John Cush RheumNow ( View Tweet)

Comparison of MSU crystal ID, DECT scanning and US to Dx gout - study of 147 pts. Compared to the gold standard (MSU ID), Feet/ankles (87% sensitivity; 100% specificity) or knees DECT (91% & 87%) alone had best Dx accuracy. US was inferior to DECT. https://t.co/h8ctkfeadZ

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: Paucity of Effectiveness Research on Telemedicine in RA https://t.co/AoKnIZCYgA https://t.co/MCBfVoEvBX

Links:

Dr. John Cush RheumNow ( View Tweet)
While RA incurrs a 2 fold risk of CHF; the use of HCQ does not add to a CHF risk. Mayo nested case-control study, compared RA w/ CHF vs nonCHF RA pts, showing HCQ use, nor duration of use, failed to increase CHF (OR: 0.96).https://t.co/Tx9jr07C7i

Links:

Dr. John Cush RheumNow ( View Tweet)

We are just weeks away from RheumNow Live--will you be attending? https://t.co/vJlU0Z3Q3x https://t.co/i1BhS4JQgi

Links:

Dr. John Cush RheumNow ( View Tweet)
×